When a mitochondrial mutation causes one sibling to be bedridden, one to have mild fatigue, and one to be asymptomatic — all three having inherited the same mutation from the same mother — that is heteroplasmy, not variable expressivity. The surface appearance is identical: same gene, different severity between individuals. The mechanisms are completely different. Variable expressivity involves nuclear genes modified by environmental or genetic modifiers. Heteroplasmy involves the physical ratio of mutant to normal mitochondria, which shifts randomly with every cell division.
The common mistake
On a connect-wave synthesis question, Maya — a Step 1 student working through the genetics inheritance cluster — was given two family scenarios side by side. Family A: a mother with mitochondrial myopathy has three children, all of whom inherited the mutation, with one severely affected, one mildly affected, and one asymptomatic. Family B: a grandfather with Huntington's develops it mildly, his son in his 40s, his grandson at 22.
Maya correctly identified Family B as anticipation. For Family A, she wrote: "variable expressivity."
The reasoning makes perfect sense at first glance. Variable expressivity is, by definition, the same mutation producing different severity between individuals. That is literally what Family A describes. The trap is that the surface pattern — same mutation, different severity — appears in both variable expressivity and heteroplasmy. Without checking the inheritance pattern, the two are visually indistinguishable.
A lot of students make this same call. The entry note from Maya's session flagged it before the session even started: heteroplasmy was listed as a repeated exam miss. Then it happened exactly as predicted — the connect-wave question surfaced the gap on cue.
The actual mechanism
The distinguishing rule is not about severity — it is about inheritance. Maternal inheritance plus variable severity between individuals equals heteroplasmy. Nuclear gene mutations (the source of true variable expressivity) follow autosomal dominant, autosomal recessive, or X-linked patterns. They do not come exclusively from the mother. When you see maternal-only transmission combined with variable severity, that combination should immediately trigger heteroplasmy as the mechanism.
Here is why severity varies in heteroplasmy specifically. The mother's oocyte contains a pool of mitochondria — some mutant, some normal. When the fertilized egg divides, mitochondria distribute randomly between daughter cells. There is no mechanism controlling how many mutant copies each daughter cell receives. That random segregation continues throughout development. By the time organs form, each tissue — and each sibling, starting with a different initial ratio — ends up with a different proportion of mutant mitochondria. That proportion determines severity.
Variable expressivity, by contrast, reflects the influence of nuclear modifier genes, epigenetic factors, and environment on how strongly a gene is expressed. The mitochondrial ratio is not involved. A mutation in NF1 or BRCA1 can show variable expressivity, but the transmission pattern will follow Mendelian inheritance, not maternal-only.
The threshold effect adds a second layer for Step 1. Tissues with the highest energy demand — skeletal muscle, cardiac muscle, brain, and retina — hit the threshold where mutant mitochondria overwhelm normal ones before other tissues. Skin and connective tissue have glycolytic fallback. High-demand tissues are almost entirely dependent on oxidative phosphorylation, so they are the first to show disease. That is why mitochondrial myopathy, MELAS, MERRF, and Leber's optic neuropathy all target muscle and neural tissue.
The genomic imprinting diseases Prader-Willi and Angelman syndrome are sometimes confused with this cluster because they also involve parent-of-origin effects, but the mechanism is entirely different — it involves epigenetic silencing set during gametogenesis, not mitochondrial copy ratios.
How to remember it
Two-part trigger. If you see maternal inheritance, ask: mitochondrial? If the answer is yes, and you see variable severity between siblings, the answer is heteroplasmy — not expressivity, not penetrance, not anticipation.
The one-line anchor: maternal + variable severity = heteroplasmy; nuclear + variable severity = expressivity.
Check yourself
A woman has MELAS syndrome. She has four children: one with severe encephalopathy, one with mild exercise intolerance, one with sensorineural hearing loss only, and one who is asymptomatic. All four inherited the mtDNA mutation.
What best explains the difference in disease severity among the siblings?
A) Variable expressivity — nuclear modifier genes altered phenotypic severity in each child
B) Incomplete penetrance — the mutation failed to express in the asymptomatic sibling
C) Heteroplasmy — each sibling inherited a different proportion of mutant to normal mitochondria
D) Anticipation — the mitochondrial mutation expanded with each successive generation
C. Maternal inheritance combined with variable severity between siblings is the signature of heteroplasmy. The proportion of mutant mitochondria in each child was set by random segregation during oogenesis and continued randomly throughout development — not by modifier genes (A), penetrance effects (B), or repeat expansion (D).
Close the gap
The tutor that caught Maya's "variable expressivity" answer in real time — during a connect-wave synthesis question designed to surface exactly this trap — is the same tutor available to every Step 1 student on Gradual Learning. It finds your specific pattern-match errors, not the generic ones.